PHARMACEUTICALS covers patent-protected prescription medicines, with news relating to drugmakers, their financial performance, licensing, research and merger & acquisition activities. This also reports on health care markets, patent developments, legislation, product approvals and delays around the globe, backed by a massive archive from which developments in all these areas can be tracked.
Lundbeck and Takeda's Brintellix shows positive results in Ph III major depression study
20 May 2013
Danish CNS specialist Lundbeck (LUND: DC) and partner Takeda Pharmaceutical (TYO: 4502), Japan's
Latest Pharma Letter Articles
Access to medicines in Europe: the EU cannot save banks while sacrificing people's health
20 May 2013
In a seminar hosted last week by the Group of the Progressive Alliance of Socialists & Democrats
Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
20 May 2013
One of the most important preconditions for Turkey to reach a reformist, sustainable economic
HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
20 May 2013
While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing
Elan makes "transformational" acquisitions and a divestment
20 May 2013
Ireland-headquartered Elan Corp (NYSE: ELN) (Elan) this morning announced a series of transactions
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
20 May 2013
India's National Pharmaceutical Pricing Authority (NPPA) last week announced plans that will
SciClone gains China rights to Zensun's Neucardin
20 May 2013
USA-based SciClone Pharmaceuticals (Nasdaq: SCLN) today announced that the Company has entered
News From the Web
Ace and XL sued by pharmaceutical giant
15 January 2013
News From the Web
Ace and XL sued by pharmaceutical giant
15 January 2013
No break in sight for pharmaceutical monopoly
15 January 2013
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
